Ipsen SA - Asset Resilience Ratio

Latest as of June 2025: 21.63%

Ipsen SA (IPN) has an Asset Resilience Ratio of 21.63% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of Ipsen SA to assess the company's strategic physical and investment asset allocation.

Liquid Assets

€1.48 Billion

≈ $1.73 Billion USD Cash + Short-term Investments

Total Assets

€6.83 Billion

≈ $7.99 Billion USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2002–2024)

This chart shows how Ipsen SA's Asset Resilience Ratio has changed over time. See IPN net asset quality score to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Ipsen SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Ipsen SA.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€1.45 Billion	21.16%
Short-term Investments	€32.30 Million	0.47%
Total Liquid Assets	€1.48 Billion	21.63%

Asset Resilience Insights

Good Liquidity Position: Ipsen SA maintains a healthy 21.63% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Ipsen SA Industry Peers by Asset Resilience Ratio

Compare Ipsen SA's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
SIMCERE PHARMAC. GRP LTD F:S2P	Drug Manufacturers - Specialty & Generic	0.44%
Curaleaf Holdings Inc. TO:CURA	Drug Manufacturers - Specialty & Generic	3.73%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Walvax BioTech SHE:300142	Drug Manufacturers - Specialty & Generic	2.20%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%

Annual Asset Resilience Ratio for Ipsen SA (2002–2024)

The table below shows the annual Asset Resilience Ratio data for Ipsen SA.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.02%	€1.10 Million ≈ $1.29 Million	€6.44 Billion ≈ $7.53 Billion	-0.15pp
2023-12-31	0.17%	€10.60 Million ≈ $12.39 Million	€6.32 Billion ≈ $7.39 Billion	-21.24pp
2022-12-31	21.40%	€1.20 Billion ≈ $1.40 Billion	€5.61 Billion ≈ $6.56 Billion	+4.23pp
2021-12-31	17.17%	€857.10 Million ≈ $1.00 Billion	€4.99 Billion ≈ $5.83 Billion	+16.55pp
2020-12-31	0.62%	€26.80 Million ≈ $31.33 Million	€4.31 Billion ≈ $5.04 Billion	-3.96pp
2019-12-31	4.58%	€197.20 Million ≈ $230.55 Million	€4.31 Billion ≈ $5.04 Billion	-1.57pp
2018-12-31	6.15%	€207.70 Million ≈ $242.82 Million	€3.38 Billion ≈ $3.95 Billion	-2.98pp
2017-12-31	9.13%	€280.60 Million ≈ $328.05 Million	€3.07 Billion ≈ $3.59 Billion	-5.91pp
2016-12-31	15.04%	€364.50 Million ≈ $426.14 Million	€2.42 Billion ≈ $2.83 Billion	+14.69pp
2015-12-31	0.35%	€6.80 Million ≈ $7.95 Million	€1.94 Billion ≈ $2.27 Billion	+0.35pp
2014-12-31	0.01%	€100.00K ≈ $116.91K	€1.71 Billion ≈ $2.00 Billion	-0.01pp
2013-12-31	0.01%	€200.00K ≈ $233.82K	€1.57 Billion ≈ $1.83 Billion	-0.02pp
2012-12-31	0.03%	€516.00K ≈ $603.26K	€1.56 Billion ≈ $1.83 Billion	+0.03pp
2011-12-31	0.00%	€9.00K ≈ $10.52K	€1.63 Billion ≈ $1.91 Billion	0.00pp
2010-12-31	0.00%	€49.00K ≈ $57.29K	€1.68 Billion ≈ $1.96 Billion	-0.07pp
2009-12-31	0.07%	€1.16 Million ≈ $1.36 Million	€1.58 Billion ≈ $1.84 Billion	-0.09pp
2008-12-31	0.16%	€2.53 Million ≈ $2.96 Million	€1.57 Billion ≈ $1.84 Billion	-0.30pp
2007-12-31	0.46%	€6.10 Million ≈ $7.13 Million	€1.32 Billion ≈ $1.55 Billion	+0.39pp
2006-12-31	0.07%	€901.00K ≈ $1.05 Million	€1.21 Billion ≈ $1.42 Billion	+0.07pp
2005-12-31	0.00%	€18.00K ≈ $21.04K	€942.51 Million ≈ $1.10 Billion	-11.71pp
2004-12-31	11.71%	€72.59 Million ≈ $84.86 Million	€619.71 Million ≈ $724.51 Million	-1.40pp
2003-12-31	13.12%	€87.34 Million ≈ $102.11 Million	€665.90 Million ≈ $778.50 Million	-3.85pp
2002-12-31	16.97%	€112.39 Million ≈ $131.39 Million	€662.33 Million ≈ $774.34 Million	--

pp = percentage points

About Ipsen SA

PA:IPN France Drug Manufacturers - Specialty & Generic

Market Cap

$14.88 Billion

€12.73 Billion EUR

Market Cap Rank

#2185 Global

#43 in France

Share Price

€154.50

Change (1 day)

-2.83%

52-Week Range

€100.80 - €172.90

All Time High

€172.90